ARCHIVES

Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards

This article is from The Cancer Letter archive.

Vol. 35 No. 30 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

Starr Foundation Gives $100 Million To Form Cancer Consortium.

September 29, 2006

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

March 21, 2003

In Brief: Innovative Antismoking Efforts Needed, CCRAC Told, Illinois To Go After Neutron Contract

December 8, 1978

FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism

November 27, 1998

Advisors approve set-aside for alternative medicine “best case series.”

November 19, 2004

Bioethics Commission Report Calls For funding To Derive Stem Cells

September 17, 1999